Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Org Chem ; 87(18): 12297-12305, 2022 09 16.
Artigo em Inglês | MEDLINE | ID: mdl-36047721

RESUMO

A flow chemistry process for the generation and use of acylketene precursors through extrusion of nitrogen gas is reported. Key to the development of a suitable continuous protocol is the balance of reaction concentration against pressure in the flow reactor. The resulting process enables access to intercepted acylketene scaffolds using volatile amine nucleophiles and has been demonstrated on the gram scale. Thermal gravimetric analysis was used to guide the temperature set point of the reactor coils for a variety of acyl ketene precursors. The simultaneous generation and reaction of two reactive intermediates (both derived from nitrogen extrusion) is demonstrated.


Assuntos
Aminas , Nitrogênio , Temperatura
2.
J Org Chem ; 83(9): 5160-5176, 2018 05 04.
Artigo em Inglês | MEDLINE | ID: mdl-29644851

RESUMO

This article describes our efforts toward the total synthesis of actinoranone. Our synthesis strategies rely on a convergent route to connect the terpenoid and polyketide fragments, employing catalysis and powerful classical reactions for the assembly of these key fragments. A new transformation was disclosed during this work, a domino ring-opening and esterification. Initial cytotoxic studies for the selected synthesis intermediates are also presented.


Assuntos
Antineoplásicos/síntese química , Antineoplásicos/farmacologia , Diterpenos/síntese química , Diterpenos/farmacologia , Antineoplásicos/química , Técnicas de Química Sintética , Diterpenos/química , Células HCT116 , Humanos , Modelos Moleculares , Conformação Molecular
3.
An Acad Bras Cienc ; 90(1 Suppl 2): 1131-1174, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29873673

RESUMO

We present a comprehensive review of the advent and impact of continuous flow chemistry with regard to the synthesis of natural products and drugs, important pharmaceutical products and definitely responsible for a revolution in modern healthcare. We detail the beginnings of modern drugs and the large scale batch mode of production, both chemical and microbiological. The introduction of modern continuous flow chemistry is then presented, both as a technological tool for enabling organic chemistry, and as a fundamental research endeavor. This part details the syntheses of bioactive natural products and commercial drugs.


Assuntos
Automação/métodos , Produtos Biológicos/química , Desenho de Fármacos , Preparações Farmacêuticas/química , Tecnologia Farmacêutica/métodos , Produtos Biológicos/síntese química , Química Farmacêutica , Preparações Farmacêuticas/síntese química
4.
Chem Soc Rev ; 42(23): 8849-69, 2013 Dec 07.
Artigo em Inglês | MEDLINE | ID: mdl-23999700

RESUMO

The development and application of continuous flow chemistry methods for synthesis is a rapidly growing area of research. In particular, natural products provide demanding challenges to this developing technology. This review highlights successes in the area with an emphasis on new opportunities and technological advances.


Assuntos
Produtos Biológicos/síntese química , Alcaloides/síntese química , Alcaloides/química , Amidas/síntese química , Amidas/química , Artemisininas/síntese química , Artemisininas/química , Produtos Biológicos/química , Colecalciferol/síntese química , Colecalciferol/química , Neurotoxinas/síntese química , Neurotoxinas/química , Oxazóis/síntese química , Oxazóis/química , Estilbenos/síntese química , Estilbenos/química , Terpenos/síntese química , Terpenos/química
5.
ACS Omega ; 5(29): 18472-18483, 2020 Jul 28.
Artigo em Inglês | MEDLINE | ID: mdl-32743225

RESUMO

An integrated batch and continuous flow process has been developed for the gram-scale synthesis of goniothalamin. The synthetic route hinges upon a telescoped continuous flow Grignard addition followed by an acylation reaction capable of delivering a racemic goniothalamin precursor (16) (20.9 g prepared over 3 h), with a productivity of 7 g·h-1. An asymmetric Brown allylation protocol was also evaluated under continuous flow conditions. This approach employing (-)-Ipc2B(allyl) provided an (S)-goniothalamin intermediate in 98% yield and 91.5% enantiomeric excess (ee) with a productivity of 1.8 g·h-1. For the final step, a ring-closing metathesis reaction was explored under several conditions in both batch and flow regimes. In a batch operation, the Grubbs second-generation was shown to be effective and highly selective for the desired ring closure product over those arising from other modes of reactivity, and the reaction was complete in 1.5 h. In a flow operation, reactivity and selectivity were attenuated relative to the batch mode; however, after further optimization, the residence time could be reduced to 16 min with good selectivity and good yield of the target product. A tube-in-tube reactor was investigated for in-situ ethylene removal to favor ring-closing over cross-metathesis, in this context. These results provide further evidence of the utility of flow chemistry for organometallic processing and reaction telescoping. Using the developed integrated batch and flow methods, a total of 7.75 g of goniothalamin (1) was synthesized.

6.
Org Lett ; 19(12): 3163-3166, 2017 06 16.
Artigo em Inglês | MEDLINE | ID: mdl-28562055

RESUMO

The syntheses of the polyketide and terpenoid fragments of actinoranone are reported in a concise fashion, relying on catalytic methods. Minimization on the use of protecting groups and redox reactions allowed the synthesis of the carbon backbone of actinoranone in 20 steps (11 steps for LLS). The asymmetric synthesis of labda-7,13-(E)-dien-15-ol is also disclosed.

7.
Medchemcomm ; 8(4): 755-766, 2017 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-30108794

RESUMO

This work describes the total synthesis of the alkaloid cenocladamide and a concise library of nine structural analogues aiming at their evaluation against the breast cancer cell line MDA-MB-231. The most promising compound (3; IC50 = 6.6 µM) was also evaluated in a panel of seven breast cancer cell lines and two non-tumorigenic cell lines. We further conducted an initial investigation on the mechanism of action of analogue 3, which lacks the endocyclic double bond when compared to cenocladamide. The present study presents the discovery of a cenocladamide analogue with interesting cytotoxic activity, which could be useful for further optimization towards new chemotherapeutic agents for breast cancer treatment.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA